To study the effect of Virechan on plasma SCFA (Short Chain Fatty Acid) levels in Twak Vikar subjects.

Exploration of effect of Virechan on plasma SCFA (Short Chain Fatty Acid) levels in Twak Vikar subjects, an observational study. - NIL

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/071796

Enrollment

Registered

2024-08-01

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects coming to Panchakarma OPD presenting with Twak Vikara. 2. Subjects posted for Virechan by the Panchakarma Dept. of Bharati Vidyapeeth (Deemed to be University) College of Ayurved and Hospital Pune.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactating mothers will be excluded. 2. Subjects Contra-Indicated for Virechan Karma. 3. Subject with ano-rectal disorders. 4 Subject who has undergone Panchakarma procedure in last 3 months. 5. Subjects having Hypertension, Diabetes Mellitus and other chronic and acute diseases, Hypothyroidism, Cushing Syndrome, Immuno-compromised disorders. 6. Subjects having Congenital and Genetic Disorders.

Design outcomes

Primary

Measure	Time frame
Changes in plasma SCFA levels in 2 plasma samplesTimepoint: 1 day before starting snehapana, and 1 day after completion of sansarjana karma	—

Secondary

Measure	Time frame
Changes in plasma SCFA levels with respect to reduction/ no reduction in signs and symptoms of Twak VikarTimepoint: Before starting snehapana, after completion of sansarjana karma	—

Countries

India

Contacts

Public ContactDr. Lata Dhananjay Patil

Hospital of Ayurveda Bharati Vidyapeeth

drpatillata1626@gmail.com9403782466

Outcome results